The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

What could lead to a further doubling, pushing the stock beyond $22? Let’s clarify the situation and analyze the concrete ...

This shift is reflected in both ambition and execution, with 74% expecting budgets to rise again next year. These findings ...

The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in ...

Wirex’s 2025 Transparency Report details fraud prevention, AML actions, sanctions screening, and regulator engagement.

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

Korrapati's implementation work is complemented by industry engagement, including presenting on CSA implementation and roadblocks at professional venues ...

Visionary Women Redefining Success in 2026 Success continues to take on new meaning as women across industries lead with ...

Urinary system tumors are a group of tumors that occur in the kidney, ureter, bladder and urethra, of which bladder cancer is the most common, followed by ...

How AIR used disciplined engineering, cargo-first operations, and early regulatory alignment to turn eVTOL test flights into ...